KLP Kapitalforvaltning’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.26M Buy
28,400
+3,600
+15% +$392K 0.01% 537
2026
Q1
$2.29M Buy
24,800
+800
+3% +$80.3K 0.01% 663
2025
Q4
$2.45M Buy
24,000
+200
+0.8% +$17.9K 0.01% 637
2025
Q3
$1.49M Buy
23,800
+1,000
+4% +$54.4K 0.01% 814
2025
Q2
$1.19M Sell
22,800
-700
-3% -$31.3K 0.01% 887
2025
Q1
$1M Sell
23,500
-1,300
-5% -$56.1K ﹤0.01% 937
2024
Q4
$758K Buy
+24,800
New +$698K ﹤0.01% 1119

Other funds holding GH

KLP Kapitalforvaltning's GH Position: Q2 2026 in Review

KLP Kapitalforvaltning increased its Guardant Health (GH) stake by 15% in Q2 2026, buying an estimated $392K and bringing the position to 28,400 shares worth $4.26M. The position accounts for 0.01% of the portfolio, ranked #537.

KLP Kapitalforvaltning first reported a position in GH in Q4 2024 and has held it in 7 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • KLP Kapitalforvaltning held 28,400 shares of Guardant Health worth $4.26M as of Q2 2026.
  • KLP Kapitalforvaltning bought 3,600 Guardant Health shares in Q2 2026, an estimated $392K.
  • Guardant Health made up 0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #537 holding.
  • KLP Kapitalforvaltning first reported a position in Guardant Health in Q4 2024 and has held it in 7 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.